FDA’s Rejection of Moderna’s Flu Vaccine Signals a Potential Shift in Vaccine Regulation Nearly a billion dollars. That’s approximately how much Moderna invested in a Phase 3 clinical trial for…
You can read the full story here: Moderna Flu Vaccine: FDA Review Delay & President’s Response.